Expand LXEO Menu
LXEO MENU

LXEO Stock Posts


Unusual Option Volume

LXEO Lexeo Therapeutics7.51-3.03 (-28.8%)

Lexeo Therapeutics trades 4,365 contracts. The company has the following event: Lexeo Therapeutics Interim Phase I/II Data Webcast for LX2020 on Jan 12, 2026. News: Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
View Details...
LXEO #LexeoTherapeutics stock declines -13.9% in premarket,

Premarket Decliner

LXEO Lexeo Therapeutics10.54+1.07+11.3%

Premarket:9.08-1.46 (-13.9%)

Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy

Globe NewswireMon, 12-Jan 7:00 AM
Unusual Option Volume

LXEO Lexeo Therapeutics10.18+0.71 (+7.5%)

Lexeo Therapeutics trades 3,423 contracts. The company has the following event: 44th Annual J.P. Morgan Healthcare Conference on Jan 14, 2026.
View Details...
LXEO #LexeoTherapeutics stock declines -17.6% in premarket,

Premarket Decliner

LXEO Lexeo Therapeutics17.60+0.16+0.9%

Premarket:14.51-3.09 (-17.6%)

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

Globe NewswireMon, 15-Jul 6:00 AM
Load Earlier Posts
Market Data Delayed 15 Minutes